NO-dependent regulation of lectin- and menadione-induced H2O2 production by cells from pleural effusions of lung cancer patients and by immune cells

International Journal of Oncology

Volumn 14, Issue 4, 1999, Pages 793-798

  Timoshenko, Alexander V ^a   Dubovskaya, Lyudmila V ^a   Karvatskaya, Olga D ^a   Zharkov, Vladimir V ^b   André, Sabine ^c   Gabius, Hans Joachim ^c  

^a BELARUSIAN STATE UNIVERSITY   (Belarus)

^b Research Institute of Oncology and Medical Radiology of the Ministry of Health of the Byelorussian SSR   (Belarus)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Hydrogen peroxide; Lectin; Leukocyte; Lung cancer; Nitric oxide; Pleural effusion

Indexed keywords

HYDROGEN PEROXIDE; LECTIN; NITRATE; NITRIC OXIDE; NITRITE; POTASSIUM DERIVATIVE; POTASSIUM NITRATE; POTASSIUM NITRITE; VITAMIN K GROUP;

ADULT; AGED; ANIMAL; ARTICLE; DRUG EFFECT; FEMALE; HUMAN; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PLEURA EFFUSION; RAT; THYMUS;

ADULT; AGED; ANIMALS; FEMALE; HUMANS; HYDROGEN PEROXIDE; LECTINS; LEUKOCYTES, MONONUCLEAR; LUNG NEOPLASMS; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; PLEURAL EFFUSION, MALIGNANT; POTASSIUM COMPOUNDS; RATS; THYMUS GLAND; VITAMIN K;

EID: 0033111011     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.4.793     Document Type: Article

References (43)

1. Cross AR and Jones OTG: Enzymatic mechanisms of superoxide production. Biochim Biophys Acta 1057: 281-298, 1991.
2. Knowles RG and Moncada S: Nitric oxide synthases in mammals. Biochem J 298: 109-142, 1994.
3. Elstner EF: Der Sauerstoff: Biochemie, Biologie, Medizin. BI-Wiss. Verlag, Mannheim, 1990.
4. Moncada S, Palmer RMJ and Higgs EA: Nitric oxide: physiology, pathophysioloey, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
5. Lala PK: Significance of nitric oxide in carcinogenesis, tumor progression and cancer therapy. Cancer Metastasis Rev 17: 1-6, 1998.
6. Clancy RM, Leszczynska-Piziak J and Abramson SB: Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 90: 1116-1121, 1992.
7. Forslund T and Sundqvist T: Nitric oxide reduces hydrogen peroxide production from human polymorphonuclear neutrophils. Eur J Clin Invest 25: 9-14, 1995.
8. Fujii H, Ichimori K, Hoshiai K and Nakazawa H: Nitric oxide inactivates NADPH oxidase in pig neutrophils by inhibiting its assembling process. J Biol Chem 272: 32773-32778, 1997.
9. Rubanyi GM and Vanhoutte PM: Oxygen-derived free radicals, endothelium and responsiveness of vascular smooth muscle. Am J Physiol 250: H815-H821, 1986.
10. Ding AH, Nathan CF and Stuehr DJ: Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J Immunol 141: 2407-2412, 1988.
11. Zhou W, Zhong C, Sun A and Gu Y: Arginine administration reduces hydrogen peroxide in ischemia-reperfusion endothelium of rats. Acta Histochcm Cytochem 30: 525-529, 1997.
12. Brüne B, Götz C, Meßmer UK, Sandau K, Hirvonen MR and Lapctina EG: Superoxide formation and macrophage resistance to nitric oxide-mediated apoptosis. J Biol Chem 272: 7253-7258, 1997.
13. Murphy MP, Packer MA, Scarlett JL and Martin SW: Peroxynitrite: a biologically significant oxidant. Gen Pharmacol 31: 179-186, 1998.
14. Weitzman SA and Gordon LI: Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 76: 655-663, 1990.
15. Ohshima H and Bartsch H: Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in cancerogenesis. Mutat Res 305: 253-264, 1994.
16. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V and Moncada S: Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54: 1352-1354, 1994.
17. Cobbs CS, Brenman JE, Aldape KD, Bredt DS and Israel MA: Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 55: 727-730, 1995.
18. Morel F, Doussiere J and Vignais PV: The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects. Eur J Biochem 201: 523-546, 1991.
19. Jones OTG and Hancock JT: Assays of plasma membrane NADPH oxidase. Methods Enzymol 233: 222-229, 1994.
20. Timoshenko AV and Cherenkevich SN: Glycobiological aspects of the activation of phagocytes' respiratory chain. Biopolimery i Kletka (in Russian) 10: 58-66, 1994.
21. Thor H, Smith MT, Hartzell P, Bellomo G, Jewell SA and Orrenius S: The metabolism of menadione (2-methyl-1,4-naphtoquinone) by isolated hepatocytes. A study of the implication of oxidative stress in intact cells. J Biol Chem 257: 12419-12425, 1982.
22. 2O, by rat thymocytes. Biochem Mol Biol Int 40: 1149-1158, 1996.
23. Argenius V, Gustafsson LE and Widstrom O: Tumor necrosis factor-α and nitric oxide, determined as nitrite, in malignant pleural effusion. Respir Mcd 88: 743-748, 1994.
24. G-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice. Br J Cancer 73: 189-196, 1996.
25. Light RW: Pleural Diseases. Lea & Febiger, Philadelphia, 1983.
26. Timoshenko AV, Kayser K, Kaltner H, André S and Gabius HJ: Binding capacities of two immunomodulatory lectins, carrier-immobilized glycoligands and steroid hormones in lung cancer and the concentration of nitrite/nitrate in pleural effusions. Lung Cancer 14: 75-84, 1996.
27. Timoshenko AV, Kayser K, Drings P, KoIb G, Havemann K and Gabius HJ: Modulation of lectin-triggered superoxide release from neutrophils of tumor patients with and without chemotherapy. Anticancer Res 13: 1789-1792, 1993.
28. Gabius HJ: Influence of type of linkage and spacer on the interaction of ß-galactoside-binding proteins with immobilized affinity ligands. Anal Biochem 189: 91-94, 1990.
29. 2 and granule enzyme release from cells. Methods Mol Med 9: 441-451, 1997.
30. Gorudko IV, Timoshenko AV, Timoshenko AP, Vacker AV, Timoshenko PA and Cherenkevich SN: Lectin-induced degranulation of neutrophils from patients with ENT diseases. Ceejohns 2: 22-27, 1997.
31. Barrett AJ: Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates. Biochem J 187: 909-912, 1980.
32. Timoshenko AV, Kayser K, Drings P, André S, Dong X, Kaltner H, Schneller M and Gabius HJ: Carbohydrate-binding proteins (plant/human lectins and autoantibodies from human serum) as mediators of release of lysozyme, elastase, and myeloperoxidase from human neutrophils. Res Exp Med 195: 153-162, 1995.
33. Liewald F, Sunder-Plassmann L, Dienemann H, Kahle H, Wulf G and Valet G: Prognostic value of flow cytometrically determined DNA-ploidy, intracellular pH and esterase activity of non-small cell lung-carcinomas. Anal Cell Pathol 4: 103-114, 1992.
34. Laszlo A, Sohar I, Karacsonyi S, Petri A and Trojan I: Activities of serum cathepsin (B, H and L) and metalloproteinase (MMP7-ase) in patients with gastrointestinal and bronchial malignant tumours. Acta Med Hung 47: 107-109, 1990.
35. Gallin JI, Seligmann BE, Cramer EB, Schiffmann E and Fletcher MP: Effects of vitamin K on human neutrophil function. J Immunol 128: 1399-1408, 1982.
36. Tzeng WF, Chiou TJ, Wang CP, Lee JL and Chen YH: Cellular thiols as a determinant of responsiveness to menadione in cardiomyocytes. J Mol Cell Cardiol 26: 889-897, 1994.
37. Riley RJ and Workman P: DT-diaphorase and cancer chemotherapy. Biochem Pharmacol 43: 1657-1669, 1992.
38. Gabius HJ: Animal lectins. Eur J Biochem 243: 543-576, 1997.
39. Gabius HJ: Concepts of tumor lectinology. Cancer Invest 15: 454-464, 1997.
40. Villalobo A and Gabius HJ: Signaling pathways for the transduction of the initial message of the glycocode into cellular responses. Acta Anat 161: 110-129, 1998.
41. Orucevic A, Hearn S and Lala PK: The role of active inducible nitric oxide synthase expression in the pathogenesis of capillary leak syndrome resulting from interleukin-2 therapy in mice. Lab Invest 76: 53-65, 1997.
42. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on interleukin 2-induced capillary leakage and antitumor responses in healthy and tumor-bearing mice. Cancer Immunol Immunother 42: 38-46, 1996.
43. Carey PD, Wakefield CH and Guillou PJ: Neutrophil activation, vascular leak toxicity, and cytolysis during interleukin-2 infusion in human cancer. Surgery 122: 918-926, 1997.